Evidence map›Paper›PMID 42002559›Full record

ArticleScientific reports2026

A multimodal explainable artificial intelligence framework for interpretable Parkinson's disease prediction.

Vaishali Mehta, Balajee Maram, Jyoti Garg, Naveen Kumar, Prakash Tukaram Raut, Anto Lourdu Xavier Raj Arockia Selvarathinam, Priya Jindal

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vaishali MehtaResearch Scholar, SR University, Warangal, Telangana, India.
Balajee MaramDepartment of AI & ML, SR University, Warangal, Telangana, India.
Jyoti GargDepartment of Computer Science & Engineering, Maharishi Markandeshwar deemed to be University, Mullana, Ambala, India.
Naveen KumarChitkara University Institute of Engineering and Technology, Chitkara University, Punjab, India. naveen.sharma@chitkara.edu.in.
Prakash Tukaram RautSymbiosis Institute of Computer Studies and Research (SICSR), Symbiosis International (Deemed University), Pune, India. prakash.raut@sicsr.ac.in.
Anto Lourdu Xavier Raj Arockia SelvarathinamDepartment of Data Science and Analytics, College of Computing, Grand Valley State University, Michigan, USA.
Priya JindalChitkara Business School, Chitkara University, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson’s disease (PD) is a complex neurological disorder that is difficult to diagnose at an early stage. Early diagnosis and prediction of the disease can help improve the prognosis of patients and therapeutic interventions. Although machine learning (ML) has shown strong potential for PD diagnosis and prediction, its clinical use is limited by the lack of model interpretability. In this study, advanced but interpretable framework is proposed for Parkinson’s disease diagnosis by incorporating explainable artificial intelligence (XAI) and machine learning methods. The proposed framework estimates the probability of PD with concise and clinically relevant explanations using heterogeneous data, including neuroimaging, motor and non-motor symptoms, and clinical features. Several ML classifiers, including support vector machines, random forests, k-nearest neighbors, and decision trees, are equipped with XAI methods, SHAP and LIME, to provide better interpretability. Under the proposed framework, the ML models demonstrated better predictive performance than classic ML models. AdaBoost achieved the best performance with an accuracy of 93%, precision of 90%, recall of 90%, a F1-score of 90%, and an AUC of 0.95, representing an improvement of approximately %0.75 in accuracy over the best-performing baseline model. In addition, local and global explanations are provided by LIME, SHAP, and ELI5 to identify essential neuroimaging and clinical features. In summary, this study provides clinical validation for AI by achieving a trade-off between predictive accuracy and interpretability, to aid early diagnosis and personalized treatment of Parkinson’s Disease.

Indexed as

Artificial IntelligenceParkinson DiseaseBoosting Machine Learning AlgorithmsClassification AlgorithmsHumansMachine LearningNeuroimagingPrediction AlgorithmsPredictive Learning ModelsRandom ForestSupport Vector MachineExplainable artificial intelligenceInterpretable modelsLIMEMachine learningParkinson’s diseaseSHAP

Identifiers

PMID42002559
PMCPMC13254398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.